Al-`Aqar Healthcare REIT Annual Report 2019

Al-`Aqar Healthcare REIT 06 FINANCIAL STATEMENT 153 Amount due to a subsidiary represents unsecured advances received from the proceeds raised from Islamic Financing by the subsidiary and expenses. The finance costs and repayment terms of the unsecured advances mirror the finance costs and repayment terms of the Islamic financing of Sukuk Ijarah raised by the said subsidiary as disclosed in Note 17. Also included in the amount due to a subsidiary are cash reserves retained by the subsidiary, the accrued profit from the cash reserves and expenses paid on behalf for the subsidiary totaling RM18,721,341 (2018: RM18,019,434) that are presented as net amount as there is a currently enforceable legal right to offset the recognised amounts and there is an intention to settle on a net basis, to realise the assets and settle the liabilities simultaneously. 21. COMMITMENTS Operating lease arrangements The Group and the Fund lease out their investment properties under operating leases. The future minimum lease receivable under non-cancellable leases are as follows: The Group The Fund 2019 2018 2019 2018 RM RM RM RM Less than one year 114,927,099 108,123,854 103,490,595 96,687,350 Between one and five years 292,312,123 306,507,852 246,566,107 296,977,432 407,239,222 414,631,706 350,056,702 393,664,782 22. FINANCIAL INSTRUMENTS Categories of financial instruments The financial instruments of the Group and the Fund are categorised into the following classes: The Group The Fund 2019 2018 2019 2018 RM RM RM RM Financial assets at amortised cost Trade receivables 13,267,472 2,246,142 4,838,597 1,216,283 Other receivables 68,214 131,893 25,158 78,085 Amounts due from a subsidiary - - 109,154,648 110,928,213 Fixed deposits with licensed banks 44,283,132 45,668,396 25,000,000 27,049,217 Cash and bank balances 43,470,684 45,680,598 26,839,607 22,639,466 101,089,502 93,727,029 165,858,010 161,911,264 Notes To The Financial Statements For The Financial Year Ended 31 December 2019 (Continued) 20. SIGNIFICANT RELATED PARTY TRANSACTIONS (CONTINUED)